Journals | Policy | Permission

Journal of Clinical Medicine Research

Editorial

Volume 8, Number 12, December 2016, pages 841-843

Why Physicians Should Look at the Mouths of Their Patients

The oral cavity is the initial portion of the digestive tract in continuity with the skin, and consequently it has anatomic, histologic, functional, and pathologic aspects related both to the skin and to the digestive system [1, 2]. Anatomically, the oral cavity includes the lips, gingivae, hard palate, cheek mucosa, tongue, floor of the mouth, and teeth placed in jaw bones; all this is bathed by saliva [1, 2]. The mouth has a very complex and varied pathology which includes infectious, autoimmune and neoplastic diseases that may affect the oral mucosa, the gnathic bones and salivary glands. Although oral pathology is an important chapter in the general pathology, the majority of doctors lack knowledge about oral diseases and their relationship with general health [3]. Therefore, it is very important to improve physicians’ information about oral pathology, especially on periodontal disease, bisphosphonate-related osteonecrosis of the jaws (BRONJ), and oral cancer.

From a microbiological point of view, the mouth is a fluvial ecosystem in which more than 500 types of microorganisms interact in a very intricate manner [4, 5]. In the flowing-water systems, life is extremely opulent and diverse on solid surfaces, where microorganisms get firm retention and a favorable nutritional environment. The mouth is the only place in the human body where such solid surfaces are found, that is, the dental surfaces [5]. The teeth are hard and non-desquamative structures that penetrate the gingiva and create a unique dentogingival microenvironment prone to colonization of innumerous bacteria species generating the subgingival biofilm [5], and the interaction between such bacteria and host defence can cause a common dental infection called periodontal disease [6]. Supragingival biofilm and tongue coating are the other main ecological niches associated with dental caries and halitosis, respectively [4].

Basically, periodontal disease can manifest as gingivitis or periodontitis [6]. Gingivitis represents a stereotyped inflammatory response to biofilm and is confined to soft tissues. In periodontitis, the inflammatory process extends to the supporting tissues, causing bone resorption, pocket formation, suppuration and eventually increased tooth mobility [5, 6]. In 1996, Offenbacher proposed the term periodontal medicine in order to establish this relationship based on human studies and animal models [7]. From this perspective, periodontitis has been suggested as a risk factor, sometimes in a bidirectional fashion, for cardiovascular diseases [8], diabetes mellitus [9], respiratory disease [10], preterm delivery [11], rheumatoid arthritis [12], osteoporosis [13], pancreatic cancer [14], metabolic syndrome [15], renal diseases [16], Alzheimer’s disease [17] and other systemic conditions. An accurate analysis of scientific evidence ensures in a more robust manner that periodontitis may be an independent risk factor for cardiovascular events, pulmonary infections and diabetes [18]. Further research is needed to confirm the relationship between periodontitis and other conditions or systemic diseases listed above.

Bisphosphonates (BPs) are a class of drugs widely used for the treatment of osteoporosis, Paget’s disease of the bone, multiple myeloma, bone metastases, and other conditions characterized by increased bone resorption [19, 20]. In 2003, Marx warned the medical profession about the association between bisphosphonate therapy and osteonecrosis of the jaws [21]. Since then, growing evidence has suggested that necrosis in the mandible and maxilla can occur as a side effect of treatment with several BPs such as pamidronate, zoledronic acid, alendronate, risedronate, and ibandronate [20].

Clinically, BRONJ is characterized by asymptomatic or painful exposure of necrotic bone in the oral cavity, lasting for more than 8 weeks in a patient receiving BPs who had not received radiation therapy to craniofacial region [22]. Such necrotic areas may undergo secondary infection and progress to abscess formation, osteomyelitis, and pathologic fractures. Usually, there may be a history of dental procedures or local trauma acting as a trigger, but in some cases, no obvious preceding factor can be identified [23]. Since the treatment of BRONJ is problematic and there are no universal guidelines for it, prevention remains the main goal [24].

The question is: why the jaws? Although the exact mechanism of BRONJ is not totally established, the answer may be related to the relatively high turnover of alveolar bone and also the exposure of the maxillofacial skeleton to the external stresses which may be physiologic (e.g., mastication), iatrogenic (e.g., dental procedures) or inflammatory (e.g., periodontal disease, caries) in nature [19]. The mandible and maxilla are covered by a thin layer of mucoperiosteal tissue, and even trauma from wearing dentures can potentially initiate osteonecrosis [25]. In the dentogingival region, the alveolar bone crest is located approximately 2 mm from the subgingival biofilm, and for that reason, bacteria and their products can easily reach to the underlying bone, as occurs in periodontal diseases [25]. Therefore, some anatomic and functional particularities make the jaw bones more vulnerable to trauma and infection and consequently to the osteonecrosis [19, 25].

Oral cancer is a major health problem worldwide. According to latest world cancer statistics (Globocan 2012) published in 2015, cancer of the lip and oral cavity accounted for 300,000 cases in 2012, being 2.1% of the world total [26]. More than 90% of all oral cancers are squamous cell carcinoma (SCC). Other less common malignancies include melanomas, carcinomas of the salivary glands, sarcomas, and metastases [27]. Tobacco use, alcoholic consumption, and betel quid chewing are the most important risk factors [28]. Oral SCC can be presented in various clinical forms. Usually, the initial lesion is a white or red patch (leukoplakia and erythroplakia, respectively) that can progress to a necrotic-looking ulcer with irregular, raised indurated borders, and infiltration of surrounding tissues [29, 30]. Treatment options for oral SCC comprise mainly surgery, radio-therapy, and systemic cytotoxic chemotherapy, or a combination of these modalities [29, 30].

It is interesting to note that although oral cancer is a serious and relatively prevalent disease, it has a great potential for early detection at the primary care level [30, 31]. Unlike other lower digestive-tract cancers that require endoscopic techniques for earlier detection, oral SCC can be promptly identified through comprehensive anamnesis and a careful physical examination [30, 31]. Unfortunately, such early diagnosis is not usual, since about 50% of oral cancer patients are diagnosed in the advanced stage, leading to mutilating surgery, difficulties on esthetic-functional rehabilitation, and poor survival rate [31].

In order to improve cure rates of oral cancer, it is imperative that healthcare practitioners, dentists, and physicians identify the patients with risk factors for developing oral SCC in their daily clinical practice [30, 31]. The major risk factors are age older than 45, combined tobacco and alcohol use or abuse, betel nut use, chronic sun exposure on the lower lip, oral human papillomavirus infection, and low intake of fruits and vegetables [32]. In these patients, comprehensive clinical examinations, including neck palpation and oral cavity inspection, should be performed routinely [30-32]. A white or red patch and non-healing ulcers, especially if they are located on the lower lip, floor of the mouth, and tongue should be suspected of being a malignant or premalignant lesion [30, 32]. These suspicious lesions should undergo biopsy immediately or else referred to a qualified professional to perform it, depending on the experience of the examining physician [30, 32].

Although the mouth has particular characteristics that create a unique milieu in the body, most physicians do not give to the oral cavity its deserved importance in the context of human health and usually keep the mouth and its problems apart from the rest of the body [33]. Indeed, many studies have shown that physicians have a low level of knowledge on oral health in general [3, 34] and on specific issues such as the relationship between periodontitis and systemic health [35, 36], BRONJ [37], and oral cancer [38, 39]. In this scenario, it is urgent that medical schools provide their students with consistent information on this topic and that general practitioners and specialists keep up to date on major oral problems. Finally, we need to improve understanding and cooperation between medicine and dentistry regarding the benefits of science and perception of human health as a whole.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

1. Gartner LP, Hiatt JL. Color Textbook of Histology. Philadelphia: W.B. Saunders, 2010. ISBN: 1416029451.
2. Fehrenbach MJ, Herring SW. Illustrated anatomy of the head and neck. St Louis: Elsevier.
3. Rabiei S, Mohebbi SZ, Patja K, Virtanen JI. Physicians' knowledge of and adherence to improving oral health. BMC Public Health. 2012;12:855.
   doi pubmed
4. Takahashi N. Microbial ecosystem in the oral cavity: Metabolic diversity in an ecological niche and its relationship with oral diseases. Int Congr Ser. 2005;1284:103-112.
   doi
5. Lindhe J. Textbook of Clinical Periodontology. Copenhagen: Munksgaard, ISBN: 978-1-4051-6099-5.
6. Wilson TG, Kornman KS. Fundamentals of Periodontics. Chicago: Quintesence Publishing Co Inc, ISBN: 978-0867154054.
7. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol. 1996;1(1):821-878.
   doi pubmed
8. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009;80(7):1021-1032.
   doi pubmed
9. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44:127-153.
   doi pubmed
10. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol. 2008;29(2):131-136.
    doi pubmed
11. Pizzo G, La Cara M, Conti Nibali M, Guiglia R. Periodontitis and preterm delivery. A review of the literature. Minerva Stomatol. 2005;54(1-2):1-14.
    pubmed
12. Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis. 2006;65(7):905-909.
    doi pubmed
13. Brennan RM, Genco RJ, Hovey KM, Trevisan M, Wactawski-Wende J. Clinical attachment loss, systemic bone density, and subgingival calculus in postmenopausal women. J Periodontol. 2007;78(11):2104-2111.
    doi pubmed
14. Chang JS, Tsai CR, Chen LT, Shan YS. Investigating the Association Between Periodontal Disease and Risk of Pancreatic Cancer. Pancreas. 2016;45(1):134-141.
    doi pubmed
15. D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93(10):3989-3994.
    doi pubmed
16. Han SS, Shin N, Lee SM, Lee H, Kim DK, Kim YS. Correlation between periodontitis and chronic kidney disease in Korean adults. Kidney Res Clin Pract. 2013;32(4):164-170.
    doi pubmed
17. Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, et al. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol. 2009;216(1-2):92-97.
    doi pubmed
18. Pizzo G, Guiglia R, Lo Russo L, Campisi G. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur J Intern Med. 2010;21(6):496-502.
    doi pubmed
19. Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, Kousteni S, et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci. 2011;1218:62-79.
    doi pubmed
20. Rosini S, Bertoldi I, Frediani B. Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks. Eur Rev Med Pharmacol Sci. 2015;19(17):3309-3317.
    pubmed
21. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115-1117.
    doi
22. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg. 2009;67(5 Suppl):2-12.
    doi pubmed
23. McLeod NM, Brennan PA, Ruggiero SL. Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review. Surgeon. 2012;10(1):36-42.
    doi pubmed
24. Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prev Community Dent. 2016;6(2):97-104.
    doi pubmed
25. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144(10):753-761.
    doi pubmed
26. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386.
    doi pubmed
27. Daley T, Darling M. Nonsquamous cell malignant tumours of the oral cavity: an overview. J Can Dent Assoc. 2003;69(9):577-582.
    pubmed
28. Yen TT, Lin WD, Wang CP, Wang CC, Liu SA. The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study. Eur Arch Otorhinolaryngol. 2008;265(11):1403-1407.
    doi pubmed
29. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4-5):301-308.
    doi pubmed
30. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52(4):195-215.
    doi
31. Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, Yildirim D. Early diagnosis of oral cancer. J Int Med Res. 2010;38(3):737-749.
    doi pubmed
32. Epstein JB, Gorsky M, Cabay RJ, Day T, Gonsalves W. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians. Can Fam Physician. 2008;54(6):870-875.
    pubmed
33. Kjellstrom B, Ryden L, Klinge B, Norhammar A. Periodontal disease - important to consider in cardiovascular disease prevention. Expert Rev Cardiovasc Ther. 2016;14(9):987-989.
    doi pubmed
34. Andersson K, Furhoff AK, Nordenram G, Wardh I. 'Oral health is not my department'. Perceptions of elderly patients' oral health by general medical practitioners in primary health care centres: a qualitative interview study. Scand J Caring Sci. 2007;21(1):126-133.
    doi pubmed
35. Quijano A, Shah AJ, Schwarcz AI, Lalla E, Ostfeld RJ. Knowledge and orientations of internal medicine trainees toward periodontal disease. J Periodontol. 2010;81(3):359-363.
    doi pubmed
36. Al-Khabbaz AK, Al-Shammari KF, Al-Saleh NA. Knowledge about the association between periodontal diseases and diabetes mellitus: contrasting dentists and physicians. J Periodontol. 2011;82(3):360-366.
    doi pubmed
37. El Osta L, El Osta B, Lakiss S, Hennequin M, El Osta N. Bisphosphonate-related osteonecrosis of the jaw: awareness and level of knowledge of Lebanese physicians. Support Care Cancer. 2015;23(9):2825-2831.
    doi pubmed
38. Canto MT, Horowitz AM, Child WL. Views of oral cancer prevention and early detection: Maryland physicians. Oral Oncol. 2002;38(4):373-377.
    doi
39. Carter LM, Ogden GR. Oral cancer awareness of general medical and general dental practitioners. Br Dent J. 2007;203(5):E10; discussion 248-249.

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Clinical Medicine Research is published by Elmer Press Inc.